Defining Insulin Resistance From Hyperinsulinemic-Euglycemic Clamps
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This study was designed to determine a cutoff point for identifying insulin resistance from hyperinsulinemic-euglycemic clamp studies performed at 120 mU/m2 ⋅ min in a white population and to generate equations from routinely measured clinic and blood variables for predicting clamp-derived glucose disposal rate (GDR), i.e., insulin sensitivity. RESEARCH DESIGN AND METHODS: We assembled data from hyperinsulinemic-euglycemic clamps (120 mU/m2 ⋅ min insulin dose) performed at the Pennington Biomedical Research Center between 2001 and 2011. Subjects were divided into subjects with diabetes (n = 51) and subjects without diabetes (n = 116) by self-report and/or fasting glucose ≥126 mg/dL. RESULTS: We found that 75% of individuals with a GDR <5.6 mg/kg fat-free mass (FFM) + 17.7 ⋅ min were truly insulin resistant. Cutoff values for GDRs normalized for body weight, body surface area, or FFM were 4.9 mg/kg ⋅ min, 212.2 mg/m2 ⋅ min, and 7.3 mg/kgFFM ⋅ min, respectively. Next, we used classification tree models to predict GDR from routinely measured clinical and biochemical variables. We found that individual insulin resistance could be estimated with good sensitivity (89%) and specificity (67%) from the homeostasis model assessment of insulin resistance (HOMA-IR) >5.9 or 2.8< HOMA-IR <5.9 with HDL <51 mg/dL. CONCLUSIONS: We developed a cutoff for defining insulin resistance from hyperinsulinemic-euglycemic clamps. Moreover, we now provide classification trees for predicting insulin resistance from routinely measured clinical and biochemical markers. These findings extend the clamp from a research tool to providing a clinically meaningful message for participants in research studies, potentially providing greater opportunity for earlier recognition of insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is no consensus on the definition of IR [145,146]”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [145]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Classification and Regression Trees.
Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,522
Classification and Regression Trees.
Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 20,825
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 2×
“The mean rate of exogenous glucose infusion during the last 30 min was defined as the GDR (1).”
BackgroundThe use of the area under the ROC curve in the evaluation of machine learning algorithms
Bradley, A. P. (1997) · Pattern Recognition · doi:10.1016/s0031-3203(96)00142-2 · Cited by 7,217 · cited 2×
“We used a receiver-operating characteristic (ROC) curve, a plot of the sensitivity versus 1 – specificity, to display the trade-off between true positives and false positives across incremental choices of discriminating cutoff points for glucose disposal rate (9,10).”
MethodA formula to estimate the approximate surface area if height and weight be known. 1916.
Bois, D. D., & Bois, E. F. D. (1989) · PubMed · Cited by 5,314
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342
Assessment of Insulin Sensitivity in Vivo*
Bergman, R. N., Finegood, D. T., & Ader, M. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-1-45 · Cited by 1,066
Statistics review 13: receiver operating characteristic curves.
Bewick, V., Cheek, L., & Ball, J. (2004) · Critical Care · doi:10.1186/cc3000 · Cited by 818 · cited 1×
“We used a receiver-operating characteristic (ROC) curve, a plot of the sensitivity versus 1 – specificity, to display the trade-off between true positives and false positives across incremental choices of discriminating cutoff points for glucose disposal rate (9,10).”
MethodClark, L. A., & Pregibon, D. (2017) · Statistical Models in S · doi:10.1201/9780203738535-9 · Cited by 560
Cited by
Items 301–382 of 382
Gastaldelli, A., Choi, E., Conde‐Knape, K., Göransson, O., Krook, A., Lehtonen, S. H., Roden, M., Schrauwen, P., Sparks, L. M., & Heni, M. (2026) · Diabetologia · doi:10.1007/s00125-026-06853-9 · Cited by 3
Hori, A., Akins, J. D., Okada, Y., Washio, T., Fukazawa, A., Vongpatanasin, W., Mizuno, M., & Fu, Q. (2026) · Clinical Autonomic Research · doi:10.1007/s10286-026-01241-0 · Cited by 1
Estimer la sensibilité à l’insuline : trop d’outils tuent-ils l’outil ?
Disse, E., Elisha, B., Fellahi, S., RABASA-LHORET, R. P. R., Laville, M., & Bastard, J. (2013) · Obésité · doi:10.1007/s11690-013-0367-8 · Cited by 1
Avcı, Y., Demir, A. R., Güler, A., Aktemur, T., Kahraman, S., Uygur, B., Demirci, G., Arslan, E., Ulutaş, A. E., & Ertürk, M. (2023) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.1183766 · Cited by 1
Dongre, S. A., Kulkarni, G. A., Thapa, D., Ghade, N. S., Lona, J., Prajapati, H. K., Mehta, H., Guttikar, S., Krishnan, A. R., & Sonar, S. M. (2025) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.1510 · Cited by 1
“21,22 Additionally, it is frequently used to investigate the PK/PD of insulin preparations.”
Deng, M., Chen, Y., Zhang, Z., & Zhang, H. (2025) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-025-08059-7 · Cited by 1
“Fifth, our assessment of IR was based on surrogate indices like HOMA-IR rather than gold-standard methods such as the hyperinsulinemic–euglycemic clamp, which may limit the precision of metabolic characterization [54].”
Tam, C. S., & Ravussin, É. (2012) · Diabetes Care · doi:10.2337/dc12-1465 · Cited by 1
Self-citationDecreased food intake contributes to elevated insulin-responsiveness in pre-clinical cancer cachexiaPreprint
Frank, E., Persson, K. W., Ogueboule, Z. K. J., Pham, T. C. P., Knudsen, J. R., Sylow, L., & Raun, S. H. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.12.711318 · Cited by 1
“Clinically, cancer is often associated with systemic insulin resistance and impaired glucose tolerance in patients[5–7] to a degree that is similar to the insulin resistance observed in patients with type 2 diabetes[8].”
Yang, Z. (2014) · Human Biology
Cardiovascular risk in young women with Polycystic OvarySyndrome
Coulson, R.-M. K. (2014) · ORCA Online Research @Cardiff (Cardiff University)
Ko, G. (2013) · QSpace (Queen's University Library)
Harfmann, B. D. (2015) · UKnowledge (University of Kentucky)
Mohiuddin, S. (2013) · NORA - Norwegian Open Research Archives
Non-Classical Progenitor Mononuclears in Metabolic Syndrome: The Role of Serum 25-Hydroxyvitamin D3
Berezin, A. Е., & Kremzer, A. A. (2016) · Clinical & Medical Biochemistry Open Access · doi:10.4172/2471-2663.1000115
Berezin, A. Е., Kremzer, A. A., Martovitskaya, Y. V., & Berezina, T. A. (2016) · Research in Cardiovascular Medicine · doi:10.5812/cardiovascmed.36580
“77 mmol/L ×μU/mL, as defined previously (23).”
Ely, B. R. (2018) · Scholars' Bank (University of Oregon)
AN OVERVIEW OF THE EFFECTS OF IRISIN ON METABOLIC DISORDERS
BERBEROĞLU, H. T., & Hacışevki, A. (2021) · Gazi Sağlık Bilimleri Dergisi · doi:10.52881/gsbdergi.861600 · Cited by 1
McIlvenna, L. C. (2021) · Victoria University Research Repository (Victoria University) · Cited by 1
Azeez, T. A. (2021) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-021-01101-0
“insulin resistance is the hyperinsulinaemic euglycaemic clamp, but it is time and resource-intensive and not clinically useful [14].”
BackgroundSoliman, H. M. A. L., Fahmy, B. S., Kadr, S. M. A. E., & Hassanein, S. A. (2022) · Pediatric Sciences Journal · doi:10.21608/cupsj.2021.108303.1040
Resistência insulínica em mulheres saudáveis em idade reprodutiva
Melhado‐Kimura, V. (2014) · doi:10.47749/t/unicamp.2014.922332
Okada, S., Watanabe, T., Okada, J., Yamada, E., Okada, K., Kikkawa, K., & Ohsima, K. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01117-9
CORRELATION OF INSULIN RESISTANCE WITH COVID-19 SEVERITY IN TYPE 2 DIABETES MELLITUS PATIENTS
Ginting, P. K., Lindarto, D., & Syafril, S. (2023) · International Journal of Research Publications · doi:10.47119/ijrp1001171120234474
Oza, C. M., Khadilkar, A. V., Mondkar, S., Amutha, A., Uppal, S., De, H., Ghosh, A. K., Khadilkar, V. V., & Mohan, V. (2023) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_411_22
“[9] However, as this is difficult and cumbersome for use in routine clinical practice, newer IS estimation equations derived by various study groups have been published.”
BackgroundCardiovascular Diseases Related to Diabetes and Obesity, volume III
Cai, L., Xin, Y., Young, J. L., & Rajesh, M. (2024) · Frontiers research topics · doi:10.3389/978-2-8325-4511-9 · Cited by 1
Волкова, Н. И., Davidenko, I. Y., Sorokina, Y. A., Degtyareva, Y. S., Vlasova, N. D., & Baeva, D. O. (2024) · Endocrinology News Opinions Training · doi:10.33029/2304-9529-2024-13-1-27-34
Davidenko, I. Y., Sorokina, Y. A., Волкова, Н. И., & Degtyareva, Y. S. (2024) · Medical Herald of the South of Russia · doi:10.21886/2219-8075-2024-15-2-61-68
Evaluation of the Triglyceride-Glucose Index with Different Generations of Beta-Adrenergic Blockers
Erciyes, D., Yıldız, C., Arpaç, A., & Çağlar, F. N. T. (2025) · Hamidiye Medical Journal · doi:10.4274/hamidiyemedj.galenos.2025.42713
Joo, M., Shin, D., Truong, X. T., Nam, S., & Lee, D. H. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0072
“The M-value of our subjects (9.35±3.52 mg/kg/min) and homeostatic model assessment for insulin resistance (HOMA-IR; 1.3±0.3) confirmed normal insulin sensitivity, considering suggested cut-off values for insulin resistance using M-value are 4.7 or 5.6 mg/kg/min [25,26].”
InfluentialZheng, S., Wang, M., Fang, Y., & Gao, Y. (2025) · Medicine · doi:10.1097/md.0000000000046260
“[31] The TyG-BMI combines glucose metabolism indicators, lipid metabolism indicators, and anthropometric indicators, which has high diagnostic value in identifying IR.”
Zhan, C., Peng, Y., Ye, H., Diao, X., Yi, C., 郭群英, Chen, W., & Yang, X. (2023) · Figshare · doi:10.6084/m9.figshare.24091810
Song, Y., Jiang, L., Han, Y., Zhang, S., & Li, S. (2024) · Figshare · doi:10.6084/m9.figshare.26410023
Liu, X., Tan, Z., Huang, Y., Zhao, H., Liu, M., Yu, P., Ma, J., Zhao, Y., Zhu, W., & Wang, J. (2022) · Figshare · doi:10.6084/m9.figshare.20218954
Shen, R., Lin, L., Bin, Z., & Qiao, X. (2024) · Figshare · doi:10.6084/m9.figshare.26750222
Ahn, S. H., Lee, H. S., & Lee, J.-H. (2024) · Figshare · doi:10.6084/m9.figshare.26700730
Ahn, S. H., Lee, H. S., & Lee, J.-H. (2024) · Figshare · doi:10.6084/m9.figshare.26700727
Salvatori, B., Linder, T., Eppel, D., Morettini, M., Burattini, L., Göbl, C., & Tura, A. (2022) · Figshare · doi:10.6084/m9.figshare.21359919
Deng, H., Hu, P., Li, H., Zhou, H., Wu, X., Yuan, M., Duan, X., Lao, M., Wu, C., Zheng, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21343205
Mahdavi‐Roshan, M., Mozafarihashjin, M., Shoaibinobarian, N., Ghorbani, Z., Salari, A., Savarrakhsh, A., & Hekmatdoost, A. (2022) · Figshare · doi:10.6084/m9.figshare.21629338
Argoty-Pantoja, A. D., Velázquez‐Cruz, R., Meneses‐León, J., Salmerón, J., & Rivera‐Paredez, B. (2023) · Figshare · doi:10.6084/m9.figshare.24209141
Yoon, J., Heo, S.-J., Lee, J.-H., Kwon, Y.-J., & Lee, J. E. (2024) · Figshare · doi:10.6084/m9.figshare.26639485
Song, Y., Jiang, L., Han, Y., Zhang, S., & Li, S. (2024) · Figshare · doi:10.6084/m9.figshare.26409895
Obesity mediated dysregulation in the expression and action of myostatin
Wilhelmsen, A. (2022) · Nottingham ePrints (University of Nottingham) · Cited by 2
Mediators of the cellular response to the development of obesity and metabolic disease
Sánchez Ceinos, J. (2021) · Universidad de Córdoba Insitutional Repository (Universidad de Córdoba)
Evans, P. R. (2023) · Hogskolan Ihalmstad (Halmstad University)
Sian, T. S. (2021) · Nottingham ePrints (University of Nottingham)
Effects of Chromium(III) Supplementation on Insulin Resistance and Diabetes – A Review [pdf]
Zbierski, K., & Krejpcio, Z. (2025) · Acta Scientiarum Polonorum Technologia Alimentaria · doi:10.17306/j.afs.001440
Wu, D., Liu, C., Zhang, J., Ge, M., Gao, B., & wang, C. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s570395
Low, S. K., Moh, A. M. C., Zheng, H., Goh, K. S., Chuan, T. B., Ang, K., Tang, W. E., Lim, Z. L. R., Subramaniam, T., Sum, C. F., et al. (2026) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2026.109270
Singhal, T., Yadav, R., & Singh, R. (2026) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20260184
Lin, W., Tang, Y., Chen, J., Liu, F., Chen, S. F., Zhang, Q., Li, X., Song, P., & Ma, X. (2026) · Hypertension in Pregnancy · doi:10.1080/10641955.2026.2627865
Timing of coffee consumption and insulin resistance: evidence from human and animal studies
Liu, P., Yao, G., Wu, Y., & Zhou, Q. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1775412
Martín‐Saladich, Q., Ciudin, A., Palomar-Muñoz, A., Gámez-Cenzano, C., Simó, R., Ballester, M. Á. G., & Herance, J. R. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1786303
Triglycerides glucose index in Madrid university students
Serrano, M. D. M., Martínez, C. P., & Despaigne, D. A. N. (2026) · Nutrición Hospitalaria · doi:10.20960/nh.06225
Mertens, J., Spinhoven, M. J., Braspenning, R., Vanhevel, F., Dirinck, E. L., Block, C. E. M. D., & Francque, S. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101887
“A cut-off value of < 4.9 mg/kg/ min was used to identify individuals with clinically significant insulin resistance, based on Tam et al. 19 After HEC, participants were supervised and could only leave when stable or increasing glucose levels were documented.”
InfluentialElbeltagi, R. M., Saeed, N. K., Bediwy, A. S., & Al‐Beltagi, M. (2026) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v15.i2.115963
Rezaianzadeh, A., Alhurry, A. M. A. H., Hajihosseini, F., Johari, M. G., Shojaei‐Zarghani, S., & Hosseini, S. V. (2026) · SAGE Open Medicine · doi:10.1177/20503121261452836
“27 Consequently, several alternative indices have been developed, including the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), which is the most widely used index calculated using fasting plasma insulin and FPG. Nonetheless, plasma insulin is not routinely measured in clinical…”
Voziki, D., Stergiou, I., Zografou, I., Mavridou, M., Teperikidis, E., Doumas, M. N., Liberopoulos, E. N., Kotsa, K., Florentin, M., & Koufakis, T. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15124403
“Direct assessment of insulin resistance using gold-standard techniques such as the hyperinsulinemic–euglycemic clamp is not feasible in routine clinical practice, while even simpler indices requiring insulin measurements are not universally available [6].”
Long, T., Hu, X., Zhang, R. X., Zhang, Z., Zhang, Z., & Chen, X. (2026) · Scientific Reports · doi:10.1038/s41598-026-56908-5
Yuan, C., Hao, Y., Wang, J., Wang, C., & Jiang, Z. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1853329
Selected Abstracts of 15th International Trakya Family Medicine Congress
TAHEK (2026) · Eurasian Journal of Family Medicine · doi:10.33880/ejfm.202615suppl2
Sanctis, V. D., Daar, S., Tzoulis, P., Soliman, A. T., Hakim, I. Z. E., Faranoush, M., & KATTAMIS, C. A. (2026) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2026.056
“26 In this single-centre retrospective analysis of 42 young adult β -TDT patients with normal fasting plasma glucose, we observed three variables of potential clinical relevance.”
Liu, Y., Meng, Z., Wang, X., & Chen, H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1862319
Huang, L., Ping, C., Ming, Y., Lei, X., & Li, L. (2026) · Neuroepidemiology · doi:10.1159/000553092
Chen, Y., & Feng, Z. (2026) · Endocrine Research · doi:10.1080/07435800.2026.2671747
“…resistance, promote each other and lead to injury of kidney glomerulus and tubules, characterized by the decline of renal function 17,21–23 . eGDR is an indicator derived from the Glucose Disposal Rate measured by the hyperin-sulinemic-euglycemic clamp test to predict insulin sensitivity 24 .”
Pre-clinical cancer cachexia causes glucose hypermetabolism prior to overt weight loss
Frank, E., Persson, K. W., Morigny, P., Ogueboule, Z. K. J., Pham, T. C. P., Knudsen, J. R., Rohm, M., Sylow, L., & Raun, S. H. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102422
“Clinically, cancer is often associated with systemic insulin resistance and impaired glucose tolerance in patients [4 — 6] similarly to the insulin resistance observed in patients with type 2 diabetes [7].”
Seyam, M. M., Elhabiby, H. A., Hamed, Z. S., Fiky, E. R. E. H. E., Elgebaly, M. M., & Aboeida, R. A. (2026) · Scientific Reports · doi:10.1038/s41598-026-65484-7
Obaro, V. E. (2026) · Scholarship & Creative Works - Digital UNC a service of University Libraries (University of Northern Colorado)
Insulin resistance beyond adiposity: Recognizing non-obese phenotypes
Shaooli, R. C. (2026) · Obesity Medicine · doi:10.1016/j.obmed.2026.100736
Huang, Z., Jian, L., Xiang, J., Du, Y., Liu, S., Lu, Y., & Zhu, X. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.10.48
Fulvio, M. D. (2026) · Toxicological Sciences · doi:10.1093/toxsci/kfag103
Wang, Y., Yao, H., Li, L., & Du, R. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1853266
Huang, S., Lin, J., Ye, L., Fang, F., Wu, Y., Liang, X., Ran, J., Wei, Z., Hu, F., Lan, Y., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1933816
“The hyperinsulinemic-euglycemic clamp remains the reference method, whereas HOMA-IR requires fasting insulin (4, 5).”
Ito, Y., Okura, T., Anno, M., Kitao, S., Endo, S., Ichihara, Y., Sawano, T., Miake, J., Ueta, E., Kato, M., et al. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70431
“However, under the present clamp conditions, the contribution of HGP is expected to be minimal 14 .”
Cai, H., Fu, Y., Zhu, F., Qiu, J., Ye, H., & Xie, E. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06822-5
“Although the hyperinsulinemic-euglycemic clamp remains the reference standard for assessing insulin resistance, its invasiveness, technical complexity, and high cost limit its application in large-scale epidemiological settings [14].”
Gluclas 2.0 — A mobile app for clinical decision support during glucose clamps
Tubaro, G., Weber, B., Cappon, G., Studer, D., Schiavon, M., Herzig, D., Man, C. D., Bally, L., & Favero, S. D. (2026) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2026.109691
Carpentier, L., Denimal, D., Rouland, A., Petit, J., de Barros, J. P. P., Duvillard, L., Bouillet, B., & Vergès, B. L. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71500
Wu, C., Wong, N. D., Chen, L., Fan, W., Seamans, M. J., Zhou, H., & Nianogo, R. A. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.103419 · Cited by 1
García, A. H., Sanctis, J. B. D., & Kubler, G. A. C. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1966524
Simonsen, S. K., Svart, M. V., Pedersen, M. G. B., Bangshaab, M., Bruun, J. M., Møller, N., & Rittig, N. F. (2026) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2026.101547
Metadata
- Authors
- Tam, C. S., Xie, W., Johnson, W. D., Cefalu, W. T., Redman, L. M., & Ravussin, E.
- Affiliations
- Pennington Biomedical Research Center (US)
- Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-06-12
- Volume
- 35
- Issue
- 7
- Pages
- 1605-1610
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3379600
- OpenAlex
- W2144789811
- Semantic Scholar
- 305e825690957f04df3471db275d0357f65dc523
- Cited by
- 364
- References
- 17
- Citations by year
- 2026: 35 · 2025: 51 · 2024: 51 · 2023: 43 · 2022: 37 · 2021: 25 · 2020: 23 · 2019: 17 · 2018: 17 · 2017: 6 · 2016: 12 · 2015: 19 · 2014: 13 · 2013: 11 · 2012: 4
- FWCI
- 12.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Civil War Book Review (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK060412, U01DK094418, P30DK072476)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R00HD060762)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- insulin resistance, hyperinsulinemic-euglycemic clamp, glucose disposal rate, insulin sensitivity, cut-off values, HOMA-IR, HDL cholesterol, classification trees, diabetes mellitus, fat-free mass
- MeSH terms
- Adult, Aged, Decision Trees, Humans, Insulin, Insulin Resistance, Middle Aged, Models, Biological, Reference Values, Glucose Clamp Technique, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.